The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.EBI
The Institute of Cancer Research
Discovery and development of heat shock protein 90 inhibitors.EBI
Memorial Sloan-Kettering Cancer Center
Identification of new Hsp90 inhibitors by structure-based virtual screening.EBI
Seoul National University
Compounds that inhibits MCL-1 proteinBDB
Amgen
Estrogen receptor modulators and uses thereofBDB
Genentech
Metallo-beta-lactamase inhibitorsBDB
Merck Sharp & Dohme
Glucosylceramide synthase inhibitors for the treatment of diseasesBDB
Biomarin Pharmaceutical
Phosphatidylinositol 3-kinase inhibitorsBDB
Gilead Sciences
Aza-peptidyl Michael Acceptors. A New Class of Potent and Selective Inhibitors of Asparaginyl Endopeptidases (Legumains) from Evolutionarily Diverse Pathogens.BDB
Georgia Institute of Technology
Azetidine based transition state analogue inhibitors of N-ribosyl hydrolases and phosphorylases.BDB
Industrial Research
Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).BDB
Bristol-Myers Squibb Pharmaceutical Research Institute